ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2.


Journal

Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007

Informations de publication

Date de publication:
09 2021
Historique:
received: 29 04 2021
accepted: 02 05 2021
pubmed: 27 6 2021
medline: 23 11 2021
entrez: 26 6 2021
Statut: ppublish

Résumé

Well-designed population-based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS-CoV-2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES-S: Reporting of Seroepidemiologic studies-SARS-CoV-2. This is an updated checklist of 22 items that should be included in the reporting of all SARS-CoV-2 seroepidemiologic studies, irrespective of study design.

Identifiants

pubmed: 34173715
doi: 10.1111/irv.12870
pmc: PMC8404052
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-568

Informations de copyright

© 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Références

Influenza Other Respir Viruses. 2021 Sep;15(5):561-568
pubmed: 34173715
Lancet Glob Health. 2021 May;9(5):e598-e609
pubmed: 33705690
Euro Surveill. 2016 Nov 3;21(44):
pubmed: 27874827
Influenza Other Respir Viruses. 2017 Jan;11(1):2-14
pubmed: 27417916
Signal Transduct Target Ther. 2020 Sep 2;5(1):180
pubmed: 32879307
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Diagnostics (Basel). 2020 May 19;10(5):
pubmed: 32438677
Front Immunol. 2020 Apr 24;11:879
pubmed: 32391022
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
PLoS One. 2021 Jun 23;16(6):e0252617
pubmed: 34161316
Clin Microbiol Infect. 2021 Mar;27(3):331-340
pubmed: 33228974

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH